Given the increasing emergence of drug resistant breast cancers and the molecular profling already conducted from breast cancer biopsies, the incorporation of BRCA1 status/localization could offer signifcant hope to patients who fail to respond to conventional therapeutics. Here, BRCA1 is linked to breast carcinoma.